Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion
Sadiq Umar, Karol Palasiewicz, Katrien Van Raemdonck, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 9, pp. 2199-2210
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Jie Huang, Xuekun Fu, Xinxin Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 222
Novel insights into macrophage diversity in rheumatoid arthritis synovium
Marie‐Astrid Boutet, Gabriel Courties, Alessandra Nerviani, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 3, pp. 102758-102758
Closed Access | Times Cited: 121
Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
Mohammed Faiz Arshad, Aftab Alam, Abdullah A. Al‐Shammari, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 3994-3994
Open Access | Times Cited: 112
Metabolic changes in fibroblast-like synoviocytes in rheumatoid arthritis: state of the art review
Zhipeng Hu, Yuan Li, Lili Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
The Discovery of 7-Isopropoxy-2-(1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-N-(6-methylpyrazolo[1,5-a]pyrimidin-3-yl)imidazo[1,2-a]pyrimidine-6-carboxamide (BIO-7488), a Potent, Selective, and CNS-Penetrant IRAK4 Inhibitor for the Treatment of Ischemic Stroke
Ryan Evans, Philippe N. Bolduc, Magnus Pfaffenbach, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4676-4690
Closed Access | Times Cited: 9
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 20
Deep Learning-Driven Library Design for the De Novo Discovery of Bioactive Thiopeptides
Jun Shi Chang, Alexander A. Vinogradov, Yue Zhang, et al.
ACS Central Science (2023) Vol. 9, Iss. 11, pp. 2150-2160
Open Access | Times Cited: 18
Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types
Sadiq Umar, Karol Palasiewicz, Michael V. Volin, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 23, pp. 7693-7707
Open Access | Times Cited: 38
Herbal compound cepharanthine attenuates inflammatory arthritis by blocking macrophage M1 polarization
Chenyang Lu, Ruijuan Cheng, Qiuping Zhang, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111175-111175
Closed Access | Times Cited: 13
Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis
Anja Meyer, Stephanie R. Zack, Wes Nijim, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 1, pp. 33-46
Closed Access | Times Cited: 13
Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
George D. Kalliolias, Efthimia K. Basdra, Athanasios G. Papavassiliou
Biomedicines (2024) Vol. 12, Iss. 1, pp. 138-138
Open Access | Times Cited: 5
Apigenin alleviates inflammation as a natural IRAK4 inhibitor
Pianchou Gongpan, Tingting Xu, Yufei Zhang, et al.
Phytomedicine (2025) Vol. 139, pp. 156519-156519
Closed Access
Interferon regulatory factor 5: a potential target for therapeutic intervention in inflammatory diseases
Xinyuan Yu, Ata Ur Rehman, Lihong Dang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Long noncoding RNA IRL regulates NF-κB-mediated immune responses through suppression of miR-27c-3p-dependent IRAK4 downregulation in teleost fish
Weiwei Zheng, Qing Chu, Tianjun Xu
Journal of Biological Chemistry (2021) Vol. 296, pp. 100304-100304
Open Access | Times Cited: 28
Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor
Katrien Van Raemdonck, Sadiq Umar, Karol Palasiewicz, et al.
Arthritis & Rheumatology (2021) Vol. 73, Iss. 11, pp. 2003-2014
Open Access | Times Cited: 28
Macrophage polarization in bone implant repair: A review
Zhengzheng Song, Yuxi Cheng, Min-Min Chen, et al.
Tissue and Cell (2023) Vol. 82, pp. 102112-102112
Open Access | Times Cited: 11
Developing potent anti-inflammatory IRAK4-targeting PROTACs with simplified CRBN ligands
Zhen Li, Peilu Song, Yujie Liu, et al.
Chinese Chemical Letters (2025), pp. 111033-111033
Closed Access
IRAK4 inhibitor mitigates joint inflammation by rebalancing metabolism malfunction in RA macrophages and fibroblasts
Sadiq Umar, Karol Palasiewicz, Michael V. Volin, et al.
Life Sciences (2021) Vol. 287, pp. 120114-120114
Open Access | Times Cited: 24
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
Anja Meyer, Ryan E Sienes, Wes Nijim, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 4, pp. 483-495
Open Access | Times Cited: 10
Emerging trends in IRAK-4 kinase research
Himanshu Yadav, Raj Kumar Shirumalla
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7825-7837
Closed Access | Times Cited: 10
New molecular targets in the treatment of rheumatoid arthritis
Beth Wallace, Laura G. Cooney, David A. Fox
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 3, pp. 235-240
Closed Access | Times Cited: 3
Fragment-Based Anti-inflammatory Agent Design and Target Identification: Discovery of AF-45 as an IRAK4 Inhibitor to Treat Ulcerative Colitis and Acute Lung Injury
Yu Zou, Xiemin Wang, Pan Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10687-10709
Closed Access | Times Cited: 3
Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming
Sadiq Umar, Karol Palasiewicz, Anja Meyer, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 15
Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein
Karol Palasiewicz, Sadiq Umar, Bianca Romay, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 9, pp. 2330-2340
Open Access | Times Cited: 17
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4
Samantha Cooray, Fiona Price-Kuehne, Ying Hong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top